Biopharma of tomorrow: Transforming through digital and data

The explosion of digital diagnostics and therapeutics, increasing patient-centeredness, interoperable data, and increased regulatory collaboration are all signs of the tremendous changes that digital technologies are driving in the health care industry. How can biopharma prepare for this new reality? How should biopharma companies transform their operating and business models to compete? In research and development (R&D), digital transformation has the potential to drastically improve productivity by applying artificial intelligence (AI) and computational biology to drug discovery and development and by making clinical trials much more efficient. In commercial, more targeted patient engagement and the application of behavioral science principles could lead to better patient outcomes. Persona-based marketing to health care providers could lead to greater market awareness and action. In supply chain, digital supply networks can result in much greater product visibility, traceability, and inventory control. How can companies leverage the promise of digital?